Fusion Antibodies plc (AIM:FAB)

Fusion Antibodies Ratios and Metrics

Market cap in millions GBP. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	16	6	4	10	16	40
Market Cap Growth	143.87%	80.40%	-64.29%	-35.83%	-61.18%	91.59%
Enterprise Value	16	6	3	9	14	37
Last Close Price	0.14	0.06	0.04	0.39	0.60	1.57
PS Ratio	9.97	3.28	3.15	3.45	3.25	9.65
PB Ratio	21.92	9.64	2.00	8.92	4.24	8.47
P/TBV Ratio	21.92	9.64	2.00	8.92	4.24	8.47
EV/Sales Ratio	10.06	3.08	2.76	3.15	2.87	8.95
Debt / Equity Ratio	0.53	0.03	0.02	0.07	0.02	0.05
Asset Turnover	0.96	1.05	0.51	0.83	0.89	0.70
Inventory Turnover	4.96	4.21	2.36	4.14	4.38	5.22
Quick Ratio	1.45	1.22	2.89	1.01	2.54	3.48
Current Ratio	1.80	2.02	3.87	1.92	3.55	4.72
Return on Equity (ROE)	-164.37%	-139.16%	-152.68%	-108.01%	-28.47%	-60.66%
Return on Assets (ROA)	-55.09%	-57.64%	-63.36%	-51.85%	-15.41%	-13.15%
Return on Capital (ROIC)	-83.45%	-85.45%	-93.61%	-73.07%	-18.97%	-15.35%
Return on Capital Employed (ROCE)	-141.50%	-246.60%	-123.70%	-244.60%	-35.70%	-25.80%
Earnings Yield	-9.22%	-26.55%	-62.24%	-25.92%	-7.69%	-7.21%
FCF Yield	-7.85%	-21.30%	-49.52%	-18.65%	-3.77%	-3.73%
Buyback Yield / Dilution	-31.30%	-72.58%	-113.55%	-0.27%	-1.91%	-15.24%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.